licensing

Eyenovia acquires US licencing rights for Formosa’s topical eye steroid

Eyenovia has acquired the exclusive licencing and commercialisation rights for APP13007 (clobetasol steroid) in the US, from the Taiwan-based Formosa…

Novartis signs $1bn licensing deal with MorphoSys and Galapagos

Novartis Pharma has signed a worldwide, exclusive agreement to licence atopic dermatitis drug candidate MOR106, which is being jointly development…